Literature DB >> 8037192

Hemolytic anemia and acute renal failure associated with temafloxacin-dependent antibodies.

R B Maguire1, D F Stroncek, E Gale, M Yearlsey.   

Abstract

Quinine-ingestion has been associated with immune-mediated recurrent pancytopenia, hemolysis, and renal failure. The structure of fluoroquinolone antibiotics is similar to the structure of quinine. Over a 3 month period, three patients at our institution developed hemolysis and renal failure following ingestion of the fluoroquinolone antibiotic temafloxacin. Two of the three patients required hemodialysis. Following withdrawal from the drug, the hemolysis resolved and the renal function eventually returned to normal in all three patients. One patient also had a transient mild thrombocytopenia. Sera from all three patients were tested for drug-dependent antibodies to red blood cells, platelets, and neutrophils. Temafloxacin-dependent red cell antibodies were detected in one patient, and temafloxacin-dependent red cell and neutrophil antibodies were detected in a second patient. No temafloxacin-dependent antibodies were detected in the third patient. Sera from all three patients were also tested for quinine and quinidine-dependent antibodies to red cells, platelets, and neutrophils. Sera from the patient without temafloxacin-dependent red cell antibodies reacted with red cells in the presence of quinine. These results suggest that, at least in some patients, the toxicities associated with temafloxacin are immune mediated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8037192     DOI: 10.1002/ajh.2830460420

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  2 in total

1.  CYP450 phenotyping and metabolite identification of quinine by accurate mass UPLC-MS analysis: a possible metabolic link to blackwater fever.

Authors:  Sean R Marcsisin; Xiannu Jin; Theresa Bettger; Nicholas McCulley; Jason C Sousa; G Dennis Shanks; Babu L Tekwani; Rajnish Sahu; Gregory A Reichard; Richard J Sciotti; Victor Melendez; Brandon S Pybus
Journal:  Malar J       Date:  2013-06-21       Impact factor: 2.979

2.  Moxifloxacin (avelox) induced thrombotic thrombocytopenic purpura.

Authors:  Sikander P Surana; Zahily Sardinas; Alan S Multz
Journal:  Case Rep Med       Date:  2012-04-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.